Trials / Completed
CompletedNCT01876121
Celecoxib Japan Observational Study for the Patients With Acute Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 784 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is to assess the safety and efficacy of celecoxib on the pain relief from acute pain.
Detailed description
Patients with traumatic pain, post-surgical and tooth extract pain will be included in this study. Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the safety will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Celecoxib | oral |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-06-12
- Last updated
- 2014-09-05
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01876121. Inclusion in this directory is not an endorsement.